4D pharma PLC | Income Statement
Fiscal year is January-December. All values GBP Thousands.
2014
2015
2016
2017
2018
Cost of Goods Sold (COGS) incl. D&A
114.00
253.00
618.00
982.00
1,201
Gross Income
114.00
253.00
618.00
982.00
1,201
SG&A Expense
3,359.00
10,337.00
12,470.00
19,379.00
27,918
EBIT
3,473.00
10,590.00
13,088.00
20,361.00
29,119
Unusual Expense
1,388.00
-
-
3,474.00
-
Non Operating Income/Expense
8.00
80.00
801.00
630.00
402
Interest Expense
-
-
71.00
3.00
2
Pretax Income
2,001.00
10,059.00
11,706.00
23,986.00
28,437
Income Tax
-
2,328.00
1,843.00
3,541.00
4,747
Equity in Affiliates
379.00
-
-
-
-
Consolidated Net Income
2,380.00
7,731.00
9,863.00
20,445.00
23,690
Net Income
2,021.00
7,547.00
9,863.00
20,445.00
23,690
Net Income After Extraordinaries
2,021.00
7,547.00
9,863.00
20,445.00
23,690
Net Income Available to Common
2,021.00
7,547.00
9,863.00
20,445.00
23,690
EPS (Basic)
0.05
0.13
0.15
0.31
0.36
Basic Shares Outstanding
42,001.90
59,823.80
64,858.20
65,084.60
65,493.80
EPS (Diluted)
0.05
0.13
0.15
0.31
0.36
Diluted Shares Outstanding
42,001.90
59,823.80
64,858.20
65,084.60
65,493.80
EBITDA
3,359.00
10,337.00
12,470.00
19,379.00
27,918
Non-Operating Interest Income
92.00
451.00
652.00
482.00
282
Minority Interest Expense
359.00
184.00
-
-
-
About 4D pharma
View Profile
